{"id":33753,"date":"2024-05-13T12:52:56","date_gmt":"2024-05-13T07:22:56","guid":{"rendered":"https:\/\/financialtelegraph.in\/index.php\/2024\/05\/13\/zseps-pharmaceuticals-a-ray-of-hope-for-side-effect-free-healing\/"},"modified":"2024-05-13T12:52:56","modified_gmt":"2024-05-13T07:22:56","slug":"zseps-pharmaceuticals-a-ray-of-hope-for-side-effect-free-healing","status":"publish","type":"post","link":"https:\/\/financialtelegraph.in\/index.php\/2024\/05\/13\/zseps-pharmaceuticals-a-ray-of-hope-for-side-effect-free-healing\/","title":{"rendered":"ZSEPS Pharmaceuticals: A Ray of Hope for Side-Effect-Free Healing"},"content":{"rendered":"
\n

\"\"<\/p>\n

Vadodara, (Gujarat) [India], May 13: <\/strong>Driven by a personal loss and a deep-seated desire to help others, Aarti Soni, founder of ZSEPS Pharmaceuticals (Zero Side Effect Pain Solution), embarked on a remarkable mission. After witnessing the devastating side effects of conventional pain medication on her brother, Soni, armed with a bachelor\u2019s degree in Home Science and two decades of diverse professional experience, set out to find a better solution.<\/p>\n

Fueled by her passion and fueled by over 150 Ayurveda Granth books, Soni poured years of research and development into creating a revolutionary line of medications. In 2024, alongside Chetan Soni and a team of dedicated doctors, ZSEPS Pharmaceuticals was born.<\/p>\n

Unveiling India\u2019s First Side-Effect-Free Alternatives<\/strong><\/p>\n

The core of ZSEPS Pharmaceuticals lies in its commitment to providing alternatives to steroids, painkillers, NSAIDs, anti-depressants, and anti-inflammatory pills. Aarti Soni and Chetan Soni have crafted specialised herbo-mineral formulations rooted in Ayurvedic wisdom. The formulations are designed to treat various ailments by addressing the root cause, making ZSEPS Pharmaceuticals a revolution in the healthcare industry.<\/p>\n

Aarti Soni\u2019s Vision:<\/strong><\/p>\n

Aarti Soni\u2019s dedication and passion have driven the development of medications effective for a range of conditions, including rheumatoid arthritis, cancer inflammation, tuberculosis, poor gut health, insomnia, attention disorders, anxiety and depression, and skin allergies. The formulations consider individual Prakruti (body type) for a personalised approach to treatment, ensuring maximum effectiveness.<\/p>\n

A Mission to Curb Iatrogenic Effects:<\/strong><\/p>\n

The launch of ZSEPS Pharmaceuticals marks a significant step towards reducing iatrogenic effects in healthcare. The company aims to contribute to a healthier society by providing side-effect-free alternatives. The formulations focus on symptomatic relief and delve into the core causes of diseases, promoting internal healing and overall well-being.<\/p>\n

The company\u2019s self-manufacturing process ensures precision in every formulation, considering nutritional and therapeutic values. The result is a comprehensive range of medications offering curable treatment without side effects.<\/p>\n

\u201cWe believe in offering a solution that alleviates symptoms and addresses the root cause of diseases. Our commitment to zero side effects is not just a business strategy; it\u2019s a personal mission born out of pain and loss. We want to provide individuals with a holistic and side-effect-free approach to healthcare,\u201d says Aarti Soni, the visionary founder of ZSEPS Pharmaceuticals.<\/p>\n

Focused on internal healing and personalised treatment, ZSEPS Pharmaceuticals is ready to influence the healthcare industry significantly, presenting a blueprint toward a healthier and side-effect-free future for all. The company proves the formidable combination of innovation and compassion, offering millions a hopeful prospect for effective and gentle solutions to their health concerns. ZSEPS Pharmaceuticals<\/a> charts a course towards a more promising future in pain management, where genuine healing and well-being become accessible to everyone.<\/p>\n

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Vadodara, (Gujarat) [India], May 13: Driven by a personal loss and a deep-seated desire to help others, Aarti Soni, founder of ZSEPS Pharmaceuticals (Zero Side Effect Pain Solution), embarked on … Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":33754,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[448],"class_list":["post-33753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business","entry"],"_links":{"self":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/33753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/comments?post=33753"}],"version-history":[{"count":0,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/33753\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media\/33754"}],"wp:attachment":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media?parent=33753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/categories?post=33753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/tags?post=33753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}